Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 13
2018 47
2019 76
2020 59
2021 60
2022 54
2023 9
Text availability
Article attribute
Article type
Publication date

Search Results

280 results
Results by year
Filters applied: . Clear all
Page 1
Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Hashimoto H, Abe M, Tokuyama O, Mizutani H, Uchitomi Y, Yamaguchi T, Hoshina Y, Sakata Y, Takahashi TY, Nakashima K, Nakao M, Takei D, Zenda S, Mizukami K, Iwasa S, Sakurai M, Yamamoto N, Ohe Y. Hashimoto H, et al. Lancet Oncol. 2020 Feb;21(2):242-249. doi: 10.1016/S1470-2045(19)30678-3. Epub 2019 Dec 11. Lancet Oncol. 2020. PMID: 31838011 Clinical Trial.
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
Gómez-Revuelta M, Pelayo-Terán JM, Juncal-Ruiz M, Vázquez-Bourgon J, Suárez-Pinilla P, Romero-Jiménez R, Setién Suero E, Ayesa-Arriola R, Crespo-Facorro B. Gómez-Revuelta M, et al. Int J Neuropsychopharmacol. 2020 Apr 23;23(4):217-229. doi: 10.1093/ijnp/pyaa004. Int J Neuropsychopharmacol. 2020. PMID: 31974576 Free PMC article. Clinical Trial.
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
Johnsen E, Kroken RA, Løberg EM, Rettenbacher M, Joa I, Larsen TK, Reitan SK, Walla B, Alisauskiene R, Anda LG, Bartz-Johannessen C, Berle JØ, Bjarke J, Fathian F, Hugdahl K, Kjelby E, Sinkeviciute I, Skrede S, Stabell L, Steen VM, Fleischhacker WW. Johnsen E, et al. Lancet Psychiatry. 2020 Nov;7(11):945-954. doi: 10.1016/S2215-0366(20)30341-2. Lancet Psychiatry. 2020. PMID: 33069317 Clinical Trial.
Olanzapine and samidorphan combination treatment: A systematic review.
Jawad MY, Alnefeesi Y, Lui LMW, Ceban F, Chen-Li DCJ, Teopiz K, Jaberi S, Gillissie ES, Vincenzo JDD, Rosenblat JD, McIntyre RS. Jawad MY, et al. J Affect Disord. 2022 Mar 15;301:99-106. doi: 10.1016/j.jad.2022.01.004. Epub 2022 Jan 7. J Affect Disord. 2022. PMID: 35007644 Review.
Olanzapine-Induced Aggression.
Smith D, Gautam M, Krayem B. Smith D, et al. Prim Care Companion CNS Disord. 2021 Feb 18;23(1):20l02719. doi: 10.4088/PCC.20l02719. Prim Care Companion CNS Disord. 2021. PMID: 34000138 Free article. No abstract available.
A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension.
Kahn RS, Silverman BL, DiPetrillo L, Graham C, Jiang Y, Yin J, Simmons A, Bhupathi V, Yu B, Yagoda S, Hopkinson C, McDonnell D. Kahn RS, et al. Schizophr Res. 2021 Jun;232:45-53. doi: 10.1016/j.schres.2021.04.009. Epub 2021 May 17. Schizophr Res. 2021. PMID: 34015555 Free article. Clinical Trial.
Olanzapine-Induced Fever.
Ferreira TF, Godinho FDG, Dehanov SD, Trancas B, Maia T. Ferreira TF, et al. Prim Care Companion CNS Disord. 2019 Feb 28;21(1):18l02332. doi: 10.4088/PCC.18l02332. Prim Care Companion CNS Disord. 2019. PMID: 30817864 Free article. No abstract available.
280 results